全文获取类型
收费全文 | 16834篇 |
免费 | 1423篇 |
国内免费 | 297篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 366篇 |
妇产科学 | 18篇 |
基础医学 | 2438篇 |
口腔科学 | 215篇 |
临床医学 | 1602篇 |
内科学 | 4786篇 |
皮肤病学 | 310篇 |
神经病学 | 137篇 |
特种医学 | 369篇 |
外科学 | 1835篇 |
综合类 | 2090篇 |
现状与发展 | 3篇 |
预防医学 | 471篇 |
眼科学 | 104篇 |
药学 | 1877篇 |
7篇 | |
中国医学 | 1843篇 |
肿瘤学 | 64篇 |
出版年
2024年 | 55篇 |
2023年 | 425篇 |
2022年 | 639篇 |
2021年 | 725篇 |
2020年 | 731篇 |
2019年 | 745篇 |
2018年 | 708篇 |
2017年 | 751篇 |
2016年 | 659篇 |
2015年 | 539篇 |
2014年 | 1104篇 |
2013年 | 2037篇 |
2012年 | 818篇 |
2011年 | 904篇 |
2010年 | 643篇 |
2009年 | 762篇 |
2008年 | 716篇 |
2007年 | 768篇 |
2006年 | 623篇 |
2005年 | 516篇 |
2004年 | 458篇 |
2003年 | 312篇 |
2002年 | 326篇 |
2001年 | 265篇 |
2000年 | 246篇 |
1999年 | 242篇 |
1998年 | 244篇 |
1997年 | 180篇 |
1996年 | 179篇 |
1995年 | 154篇 |
1994年 | 139篇 |
1993年 | 135篇 |
1992年 | 110篇 |
1991年 | 78篇 |
1990年 | 80篇 |
1989年 | 57篇 |
1988年 | 51篇 |
1987年 | 57篇 |
1986年 | 59篇 |
1985年 | 49篇 |
1984年 | 52篇 |
1983年 | 30篇 |
1982年 | 53篇 |
1981年 | 38篇 |
1980年 | 22篇 |
1979年 | 16篇 |
1978年 | 14篇 |
1977年 | 12篇 |
1976年 | 11篇 |
1975年 | 10篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
61.
Analysis of depressed cell-mediated immunity in asbestos workers 总被引:1,自引:0,他引:1
R D deShazo J Nordberg Y Baser B Bozelka H Weill J Salvaggio 《The Journal of allergy and clinical immunology》1983,71(4):418-424
To explore the mechanisms of asbestos-related perturbations of the immune system, we evaluated the in vitro cell-mediated immunity of five asymptomatic asbestos workers with hypergammaglobulinemia and decreased T-cell numbers. These results were compared with those in 10 matched controls. Analysis of T-lymphocyte populations revealed decreased absolute numbers of OKT4+ (helper/inducer) T cells in the peripheral blood and phytohemagglutinin (PHA)-stimulated mononuclear cell cultures of the workers. When chrysotile asbestos was added to PHA cultures, expansion of OKT4+ cell populations was disproportionately inhibited in workers' cultures. Furthermore, control proliferative responses to PHA became indistinguishable from initial worker responses. These effects were incompletely explained by the cytotoxic effects of asbestos on cultured lymphocytes. We conclude that both in vivo and in vitro exposure of mononuclear cell populations to asbestos may lead to a diminution of helper-inducer T-cell numbers. In asbestos-exposed individuals, this latter lymphocyte subpopulation appears to be especially sensitive to in vitro asbestos exposure. Although the clinical implications of these findings are unclear, we hypothesize that many of the immunologic abnormalities that occur in asbestos workers could be explained by direct asbestos effects on the OKT4+ immunoregulatory population. 相似文献
62.
Objective and design: To characterize rat collagen-induced arthritis (CIA) on the basis of levels of inflammatory cytokines, tumor necrosis factor (TNF)-, interleukin (IL)-1 and IL-6 in paw tissues, and further investigate the effect of FK506 (tacrolimus), a potent inhibitor of T cell activation, on cytokine levels.Methods: CIA was induced in female Lewis rats. The volume of hindpaws was measured before and after collagen immunization. TNF-, IL-1 and IL-6 levels in paw tissue extracts were determined by ELISA. Proteoglycan contents of cartilage in femoral heads was measured as an indication of cartilage destruction. To assess the effect of FK506 on inflammatory cytokine levels, rats were orally treated with 5 mg/kg of FK506 from days 14–21.Results: TNF- a level in paw tissues did not significantly change compared to levels found before collagen immunization, throughout development of CIA. In contrast, IL-1 and IL-6 levels in paw tissues significantly increased between day 14 and day 28 after collagen imuninization, when the arthritis was at a developed stage. Therapeutic treatment with FK506 reduced the elevated level of IL-6, but not IL-1, in paw tissue. FK506 treatment was effective in suppressing paw swelling and also recovering the loss of proteoglycan contents in the cartilage.Conclusions: Levels of IL-1 and IL-6, but not TNF- , in paw tissue were upregulated in association with the development of arthritis in rat CIA. These results suggest that IL-1 and IL-6, rather than TNF- , may play important roles at local inflammatory sites in producing joint destruction in rat CIA. FK506 may improve arthritis in established stages of CIA, by reducing the elevated level of IL-6.Received 4 March 2004; returned for revision 2 April 2004; accepted by M. J. Parnham 9 April 2004 相似文献
63.
The role of COX-2 in angiogenesis and rheumatoid arthritis 总被引:4,自引:0,他引:4
Woods JM Mogollon A Amin MA Martinez RJ Koch AE 《Experimental and molecular pathology》2003,74(3):282-290
Recent evidence suggests that cyclooxygenase (COX)-2 is a mediator of angiogenesis, and COX-2 activity is known to be upregulated in the rheumatoid arthritis (RA) synovium. We examined whether mediation of angiogenesis by COX-2 was occuring in cells of the RA synovium and in microvascular endothelial cells (ECs) that are similar to those found in the RA synovium. We demonstrate that rofecoxib, a selective COX-2 inhibitor, acts directly on human dermal microvascular ECs (HMVECs) to inhibit their chemotactic and tube forming ability. Likewise, pretreatment of HMVECs with rofecoxib significantly inhibited their ability to form tubes induced by conditioned media (CM) of activated RA synovial fibroblasts. When RA synovial fibroblasts were pretreated with rofecoxib for 16 h and then stimulated with interleukin (IL)-1beta, their CM induced significantly less HMVEC tube formation when compared with CM from vehicle-treated RA synovial fibroblasts. ELISAs performed on activated RA fibroblast CM for known proangiogenic factors demonstrated a significant reduction in bFGF, in addition to the expected decrease in PGE(2). Our studies suggest that COX-2-induced angiogenic activity is an active mechanism within diseased synovium and may provide an additional rationale for the use of COX-2 inhibitors in RA. 相似文献
64.
65.
Matsushita N Kashiwagi M Wait R Nagayoshi R Nakamura M Matsuda T Hogger P Guyre PM Nagase H Matsuyama T 《Clinical and experimental immunology》2002,130(1):156-161
The aim of the present study was to evaluate levels of soluble CD 163 in sera and fluids from rheumatoid arthritis (RA) patients and elucidate the mechanism that regulates the shedding of CD163. Levels of soluble CD163 in sera and fluids from RA patients were examined by a sandwich enzyme immunoassay and Western blotting. To determine the effects of tissue inhibitors of metalloproteinase (TIMPs) on the shedding of CD163 from monocytes/macrophages, levels of soluble CD163 in cultures of monocytes/macrophages and the expression of CD163 on monocytes/macrophages in the presence or absence of TIMPs were examined by a sandwich enzyme immunoassay and flow cytometry, respectively. The clinical marker that was most associated with serum levels of soluble CD163 was levels of CRP. TIMP-3, but not TIMP-1 or TIMP-2, inhibited the shedding of CD163 from monocytes/macrophages. It was shown that serum levels of soluble CD163 are a sensitive and reliable marker to monitor activated macrophages in synovitis from RA patients and the results imply that the responsible proteinase for the shedding of CD163 is not a member of the matrix metalloproteinases, but is likely to be a member of ADAMs. 相似文献
66.
T. Neumann P. Oelzner P. K. Petrow K. Thoss G. Hein G. Stein R. Bräuer 《Inflammation research》2006,55(1):32-39
Objective: To assess the effect of osteoprotegerin (OPG) on joint swelling, synovial inflammation and cartilage destruction, periarticular
and axial bone volume, and bone turnover in rat antigen-induced arthritis (AIA). Design: Rats were treated with OPG (3 mg/kg/day) at regular intervals from day 1 to day 20 of AIA. Disease activity was evaluated
by measurement of joint swelling as well as, joint inflammation and destruction by histology. Bone volume and cellular turnover
parameters of secondary spongiosa of the right tibia head and the third lumbar vertebra were evaluated by histomorphometry.
Periarticular bone volume of the primary spongiosa at the right tibia head was measured by linear scanning. The findings were
compared with those of PBS-treated AIA and healthy animals. Result: OPG treatment did not reduce joint swelling or histological signs of inflammation. Cartilage destruction was reduced. However,
this effect did not reach statistical significance . In the secondary spongiosa OPG treatment reduced the loss of periarticular
bone volume. However, the latter did not reach the level of healthy controls. OPG treatment significantly reduced parameters
of bone formation and bone resorption. In the primary spongiosa, OPG-treatment led to a higher amount of mineralized tissue
and a greater number of trabeculae compared to PBS-treated animals with AIA or healthy controls. In the axial skeleton, OPG
treatment reduced bone formation and bone resorption parameters compared to healthy animals. This treatment had no influence
on bone volume. Conclusions: In periarticular bone of AIA rats, OPG treatment reduced the loss of bone volume and decreased the bone turnover, thus preventing
periarticular bone destruction. OPG treatment had no influence on inflammatory process or on cartilage destruction.
Received 2 June 2005; returned for revision 26 July 2005; returned for final revision 9 August 2005; accepted by M. Parnham
24 September 2005
Presented in part at the 66. Annual Meeting of the American College of Rheumatology, New Orleans, U.S.A., October 2002, and
at the 25. Annual Meeting of the American Society of Bone and Mineral Research, Minneapolis, USA, September 2003
Supported by grants from the Thuringian Ministry of Science, Research and Art (B307-01025, B378-01017), the Interdisciplinary
Center for Clinical Research (IZKF) Jena, and the Deutsche Forschungsgemeinschaft (Br 1372/5-1)
Osteoprotegerin was generously provided by Amgen (Thousand Oaks, CA, USA).
Drs. Neumann and Oelzner contributed equally to this work. 相似文献
67.
IgE Anti-IgG Antibodies in Patients with Juvenile and Adult Rheumatoid Arthritis Including Felty's Syndrome 总被引:1,自引:0,他引:1
Anti-IgG; antihodies (anti-IgG) of the IgE class were studied in sera from patients with juvenile rheumatoid arthritis (JRA). rheumatoid arthritis (RA) and patients with Felty's syndrome (FS) by use of an indirect immunofluorescence technique. Forty-two percent of 26 patients with JRA had IgE anti-IgG in serum all in low titers. Positive reactions prevailed in patients with multiple joint involvement. Sixty-three percent of 30 patients with RA and 80% of 20 patients with FS had IgE anti-IgG, the titers found in FS patients being significantly higher. In JRA and FS patients the IgE anti-IgG titers were correlated to the titers of anti-IgG of the IgG class, and for FS patients also with the IgM and IgA classes of anti-IgG. In six of 10 patients with RA the synovial fluid samples from both knees contained IgE anti-IgG. In four of these patients the titers of IgE anti-IgG were higher than in the corresponding serum sample, pointing to a local production. After G-200 Sephadex chromatography IgE anti-IgG were demonstrated in the void volume indicating the presence of these autoantibodies in immune complexes. IgE anti-IgG may be involved in the pathogenesis of JRA and RA by eliciting Type I and III reactions. 相似文献
68.
Frequencies of alpha-1-antitrypsin (Pi) phenotypes were studied in 100 female and 100 male Swedish patients with classical rheumatoid arthritis and compared with the population frequencies. A significant increase of rare Pi types (MS, MZ, MF and SZ) was found among the patients. However, the increase concerned mainly Z heterozygotes and was more strongly pronounced in male patients. The M-subtypes showed no association with rheumatoid arthritis. Previous investigations of Pi types in rheumatoid arthritis have shown somewhat variable results. The results so far indicate, however, that an association between the Z allele and rheumatoid arthritis is likely to exist, while the evidence for a relationship between rheumatoid arthritis and other Pi alleles is considerably weaker. 相似文献
69.
Photodynamic therapy; a comparison with other immunomodulatory treatments of adjuvant-enhanced arthritis in MRL-lpr mice. 总被引:2,自引:2,他引:2 下载免费PDF全文
L G Ratkay R K Chowdhary H C Neyndorff J Tonzetich J D Waterfield J G Levy 《Clinical and experimental immunology》1994,95(3):373-377
Although numerous experimental immunomodulatory regimens have been reported to be effective in the treatment of rheumatoid arthritis, they also produce undesirable side effects. An alternative specific modality of localized treatment is photodynamic therapy (PDT). In this study we treated 13-week-old MRL-lpr mice whose spontaneous arthritis was enhanced by intradermal injection of Freund's complete adjuvant (FCA). One group received transcutaneous photodynamic therapy at days 0, 10, and 20, following the FCA injection. The other groups were injected with 1 mg/kg per day indomethacin, 40 mg/kg per day cyclosporin A (CsA), or treated with 3 Gy sublethal whole body irradiation (WBI). The development of swelling was monitored for 1 month, at which time proteinuria, lymphadenopathy and the histopathology of the joints and kidneys were assessed. The results demonstrated that PDT and the conventional treatments significantly ameliorated swelling of the hindlimbs from 70% in the untreated FCA-injected animals to below the 19% level characteristic of the unmanipulated control. Histological examination showed a reduction in pannus formation, and cartilage and bone destruction, the characteristics of adjuvant-enhanced arthritis. PDT did not affect the survival rate, lymphoproliferation, or proteinuria of the treated animals. However, indomethacin increased proteinuria, and was less effective in preventing cartilage and bone destruction. Furthermore, lower doses of CsA and WBI exacerbated arthritis activity. These results indicate that photodynamic therapy can inhibit the development of adjuvant-enhanced arthritis in MRL-lpr mice with similar effectiveness to the conventional treatments, but without their negative side effects. 相似文献
70.
HLA-dependent peripheral T cell receptor (TCR) repertoire formation and its modification by rheumatoid arthritis (RA) 下载免费PDF全文
N MIZUSHIMA H KOHSAKA T NANKI W E R OLLIER D A CARSON N MIYASAKA 《Clinical and experimental immunology》1997,110(3):428-433
Our previous studies have disclosed that the peripheral T cell receptor β (TCRB) gene repertoires of RA monozygotic twins were similar. This suggested that the TCRBV repertoire is controlled primarily by genetic factors. Here, we examine how the combination of HLA and presence of RA influence the peripheral TCRB repertoire. Peripheral blood mononuclear cells from six pairs of healthy monozygotic twins, six pairs of monozygotic twins discordant for RA, and nine siblings of a large family, including three RA patients, were examined for their TCRB gene repertoires. Among healthy twins and siblings, the BV repertoires between HLA-identical pairs were significantly more similar than those of HLA-non-identical pairs. When RA-affected members were included, the repertoires of the HLA-identical pairs discordant for RA were dissimilar compared with those of healthy pairs. TCRBV–BJ combination repertoire analysis of CD4 and CD8 T cell subsets from the twins showed that the dissimilarity was primarily confined to CD8 T cells in the healthy identical twins, whereas it was seen in both CD4 and CD8 T cell subsets in the RA-discordant twins. These results suggest (i) the presence of RA modifies the genetically controlled TCR repertoire of peripheral T cells, and (ii) the RA-associated alterations appear to occur more frequently in CD4 T cells than in CD8 T cells. 相似文献